This study aims to intervene in children and adolescents with ADHD using transcranial photobiomodulation, comparing its effects on executive function at the levels of electroencephalography (EEG), eye tracking, and cognitive behavior. The goal is to identify the most effective clinical treatment strategy for ADHD patients.
Age between 6 and 18 years;
Clinically diagnosed with ADHD by a psychiatrist;
Confirmed by the researcher (child psychiatrist) to meet the diagnostic criteria for Attention-Deficit/Hyperactivity Disorder as outlined in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5);
M.I.N.I. KID interview shows only ADHD, with no other comorbidities;
Diagnosis of other severe mental illnesses, such as schizophrenia or bipolar disorder;
Presence of severe physical diseases or conditions, such as significant intracranial lesions, thyroid disorders, epilepsy, congenital heart disease, severe hematologic disorders, systemic lupus erythematosus, auditory or visual impairments, etc.;
Presence of significant structural brain abnormalities on imaging studies;
Presence of severe neurological diseases with a clear family history or potential risk;
Qilu Hospital of Shandong University
Lead sponsor
Capital Medical University
Collaborator
Peking Union Medical College
Collaborator
Chinese Academy of Medical Sciences
Collaborator